Table 2.
Results of MANCOVAs (with appreciation at work predicting the latent variable CHD risk with MAP, HbA1c, TC/HDL-C ratio, the coagulation index, and the inflammatory index as dependent variables) in all participants as well as in medication-free, non-smoking participants, and post-hoc linear regression analyses with each dependent variable separately regressed on appreciation at work.
| All participants (N = 103) Without covariates (with covariates of medication intake, age, BMI, and smoking) |
Medication-free, non-smoking participants (n = 70) Without covariates (with covariates of age andBMI) |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| MANCOVAs | [dfNum, dfDen] | F | p | η2p | Wilk’s Λ | [dfNum, dfDen] | F | p | η2p | Wilk’s Λ |
| Appreciation at work | [5, 97] (5, 90) |
3.16 (2.36) | 0.011 (0.046) | 0.14 (0.12) | 0.86 (0.88) | [5, 64] (5, 62) |
3.49 (2.98) | 0.008 (0.018) | 0.21 (0.19) | 0.79 (0.81) |
| Post-hoc linear regression analyses | β | p | (Δ)R2 | β | p | (Δ)R2 | ||||
| MAP | −0.27 (−0.19) | 0.007 (0.026) | 0.07 (0.04) | −0.35 (−0.25) | 0.003 (0.011) | 0.12 (0.06) | ||||
| HbA1c | −0.14 (−0.12) | 0.15 (0.24) | 0.05 (0.06) | 0.70 (0.66) | ||||||
| TC/HDL-C ratio | −0.21 (−0.17) | 0.031 (0.079) | 0.05 (0.03) | −0.37 (−0.32) | 0.002 (0.005) | 0.14 (0.10) | ||||
| Coagulation index | 0.15 (0.16) | 0.14 (0.11) | 0.17 (0.18) | 0.15 (0.15) | ||||||
| Inflammation index | −0.10 (−0.03) | 0.34 (0.72) | −0.04 (0.01) | 0.77 (0.95) | ||||||
MAP, mean arterial pressure; TC/HDL-C ratio, total cholesterol/high-density lipoprotein-cholesterol ratio; coagulation index = averaged z-transformed levels of D-dimer and fibrinogen; inflammation index = averaged z-transformed levels of interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and C-reactive protein (CRP), n = sample size; dfNum = degrees of freedom numerator; dfDen = degrees of freedom denominator; significant values are highlighted in bold (p < 0.05).